• 作者：Julien Turk⁽¹⁾ ; Guillaume Debaty⁽²⁾ ; Nicolas Lucet⁽³⁾ ; Bastien Rouanet⁽³⁾ ; Guillaume Deschanel⁽³⁾ ; Arnaud Rohart⁽³⁾ ; Marc Latappy⁽³⁾ ; Pierre Pili⁽⁴⁾ ; Loic Belle⁽⁵⁾ ; ^{loic.belle@wanadoo.fr" class="auth_mail" title="E-mail the corresponding author}
• 刊名：Archives of Cardiovascular Diseases Supplements
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：8
• 期：1
• 页码：7-8
• 全文大小：74 K

Purpose

To evaluate the management of elderly STEMI patients treated in a formal regional network of care.

Methods

This prospective analysis, based on data from the ongoing RESURCOR coronary emergency network, involved 6169 patients presenting with an acute STEMI between 2002 and 2011 in the north French Alps.

Patients were divided into age groups: <65, 65-74, 75-84 and ≥85 years. Reperfusion rates, types, timing and adjunctive medications were compared.

The RESURCOR network advocates primary percutaneous coronary intervention (PPCI) over fibrinolysis and bivalirudin over glycoprotein inhibitors (GPI) in the elderly.

Results

Lack of reperfusion therapy increased with age (Table).

The rate of fibrinolysis was higher than that for PPCI in younger patients whereas the situation was reversed in elderly patients.

In patients who had PPCI, use of bivalirudin increased and GPI decreased with age, system delays were similar.

Conclusion

These regional French data indicate that elderly STEMI patients receive appropriate management with timely delivered PPCI and bivalirudin; however, a substantial proportion are still undertreated.